KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Return on Sales (2018 - 2025)

BioNTech SE's Return on Sales history spans 8 years, with the latest figure at 0.08% for Q4 2025.

  • On a quarterly basis, Return on Sales fell 8.0% to 0.08% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.01%, a 1.0% decrease, with the full-year FY2025 number at 0.0%, up 6.0% from a year prior.
  • Return on Sales hit 0.08% in Q4 2025 for BioNTech SE, down from 0.0% in the prior quarter.
  • Over the last five years, Return on Sales for BNTX hit a ceiling of 0.02% in Q3 2024 and a floor of 0.54% in Q2 2025.
  • Historically, Return on Sales has averaged 0.04% across 5 years, with a median of 0.0% in 2021.
  • Biggest five-year swings in Return on Sales: rose 2bps in 2024 and later tumbled -47bps in 2025.
  • Tracing BNTX's Return on Sales over 5 years: stood at 0.01% in 2021, then skyrocketed by 66bps to 0.01% in 2022, then tumbled by -67bps to 0.0% in 2023, then crashed by -100bps to 0.0% in 2024, then tumbled by -10454582bps to 0.08% in 2025.
  • Business Quant data shows Return on Sales for BNTX at 0.08% in Q4 2025, 0.0% in Q3 2025, and 0.54% in Q2 2025.